stockportfolio.pro
Gilead Sciences, Inc. P/E Ratio 2007–2025
Gilead Sciences, Inc. (GILD) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -0.4%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 17.88 | -92.3% |
| FY 2024 | 233.17 | +1306.4% |
| FY 2023 | 16.58 | -20.8% |
| FY 2022 | 20.93 | +67.8% |
| FY 2021 | 12.48 | -97.4% |
| FY 2020 | 472.77 | +3829.7% |
| FY 2019 | 12.03 | +6.5% |
| FY 2018 | 11.30 | -24.3% |
| FY 2017 | 14.92 | +191.5% |
| FY 2016 | 5.12 | -13.4% |
| FY 2015 | 5.91 | -33.2% |
| FY 2014 | 8.86 | -69.1% |
| FY 2013 | 28.66 | +85.3% |
| FY 2012 | 15.47 | +93.7% |
| FY 2011 | 7.99 | +5.9% |
| FY 2010 | 7.54 | -28.9% |
| FY 2009 | 10.60 | -38.2% |
| FY 2008 | 17.15 | -11.5% |
| FY 2007 | 19.38 | — |
Source: Gilead Sciences, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Gilead Sciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGilead Sciences, Inc. — frequently asked questions
What is Gilead Sciences, Inc.'s price-to-earnings ratio?
Gilead Sciences, Inc. (GILD) reported price-to-earnings ratio of 17.88 for fiscal year 2025, per its SEC filings.
How has Gilead Sciences, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, GILD's price-to-earnings ratio declined at roughly 0.4% per year (compound annual rate), from 19.38 to 17.88.
Where does this data come from?
Figures are computed from Gilead Sciences, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.